Extended Prophylaxis of Venous Thromboembolism with Idraparinux | Zendy

Harry R. Büller | Zendy; Ander Cohen | Zendy; Bruce L. Davidson | Zendy; Hervé Decousus | Zendy; Alexander Gallus | Zendy; Michael Gent | Zendy; G Pillion | Zendy; Franco Piovella | Zendy; Martin H. Prins | Zendy; Gary E. Raskob | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Extended Prophylaxis of Venous Thromboembolism with Idraparinux

Author(s) -

Harry R. Büller,

Ander Cohen,

Bruce L. Davidson,

Hervé Decousus,

Alexander Gallus,

Michael Gent,

G Pillion,

Franco Piovella,

Martin H. Prins,

Gary E. Raskob

Publication year - 2007

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa067703

Subject(s) - medicine , placebo , vitamin k antagonist , incidence (geometry) , anesthesia , anticoagulant , surgery , venous thromboembolism , warfarin , thrombosis , physics , alternative medicine , pathology , optics , atrial fibrillation

The extended use of vitamin K antagonists for prophylaxis against venous thromboembolism is often constrained by risk-benefit limitations and inconvenience. We evaluated the efficacy and safety of a 6-month extension of prophylaxis against recurrent venous thromboembolism with idraparinux in patients who had initially received 6 months of prophylaxis with an anticoagulant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research